Given that IRF4 was previously identified as a suppressor of MYC-driven leukemias41, the ability of ROCK2 to simultaneously promote IRF4 activation and MYC protein expression suggest that the tumor suppressor effects of IRF4 in B-cell leukemias are not dependent on ROCK2-mediated phosphorylation. The gene discussed is ROCK2; the disease is neoplasm.